SCHEMBL22978557

SCHEMBL22978557

Cc1nc(NC(=O)N2CCC(C)(C)C2C)ccc1Cc1c[nH]c2ncccc12

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.42
▸ CYP3A4 P08684 2/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ MTNR1A P48039 1/20 0.40
▸ DRD4 P21917 8/20 0.38
▸ DRD2 P14416 6/20 0.38
▸ DRD3 P35462 6/20 0.38
▸ MET P08581 1/20 0.37
▸ HCRTR1 O43613 1/20 0.37
▸ HCRTR2 O43614 1/20 0.37
▸ HSD11B1 P28845 3/20 0.36
▸ NTRK1 P04629 1/20 0.36
▸ FGFR1 P11362 1/20 0.34
▸ FGFR4 P22455 1/20 0.34
▸ CSF1R P07333 1/20 0.34
▸ KIT P10721 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22988846 0.82 CSF1R (0.45) GPR84CYP3A4CYP2C19MTNR1ADRD4
SCHEMBL22978560 0.80 GPR84 (0.41) GPR84CYP3A4CYP2C19MTNR1ADRD4
SCHEMBL22988842 0.73 GPR84 (0.49) GPR84CYP3A4CYP2C19MTNR1AMET
SCHEMBL22988865 0.70 CSF1R (0.45) CYP3A4CYP2C19MTNR1ACSF1RKIT
SCHEMBL22988876 0.69 CSF1R (0.46) CYP3A4CYP2C19MTNR1ACSF1RKIT
SCHEMBL22988862 0.69 CSF1R (0.44) CYP3A4CYP2C19MTNR1ACSF1RKIT
SCHEMBL22988863 0.68 KIT (0.45) CYP3A4CYP2C19DRD3CSF1RKIT
SCHEMBL21304797 0.68 MET (0.60) GPR84CYP3A4CYP2C19METNTRK1
SCHEMBL21873023 0.68 GPR84 (0.66) GPR84CYP3A4CYP2C19MTNR1ADRD4
SCHEMBL22978564 0.68 GPR84 (0.66) GPR84CYP3A4CYP2C19MTNR1ADRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018233526-A9 CSF1R INHIBITOR, AND MANUFACTURING METHOD THEREFOR AND APPLICATION THEREOF 上海和誉生物医药科技有限公司 2021-02-18 — — WO disclosed
Send feedback